Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

214 Results Found

Member

AHA 340B Advocacy Alliance Bulletin March 30, 2026

Submit letters on 340b rebate model by April 20.
340B Drug Pricing Program
Public

Fact Sheet: 340B Drug Pricing Program: Fact vs Fiction

For nearly 30 years, the 340B Drug Pricing Program has provided financial help to safety-net hospitals to manage rising prescription drug costs. Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to qualifying health care organizations that care for many uninsured and low-income patients.
340B Drug Pricing Program
Public

Fact Sheet: The 340B Drug Pricing Program

Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and communities they serve.
340B Drug Pricing Program, 340B Payment Reductions in the CY2018 Final OPPS Rule, AHA.org Advocacy Homepage Block
Public

AHA House E&C Testimony on Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape

AHA President and CEO Rick Pollack testimony before the House Committee on Energy and Commerce Subcommittee on Health on Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape.
Cost Management, Commercial Insurer Accountability, Making Healthcare More Affordable, Promoting Healthy Communities, Care Delivery Transformation, Innovation, Cost, Quality and Outcomes (CQO) Movement, Access to Care in Vulnerable Communities, 340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance Bulletin - March 12, 2026

Urge your Representative to sign Hill Letter on 340B Rebate Model.
340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance - March 3, 2026

The AHA today urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect by April 1.
340B Drug Pricing Program
Public

AHA Letter to HRSA Regarding a New Concerning Development with the 340B Program

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance Bulletin - February 25, 2026

The Health Resources and Services Administration today said it will extend the deadline to April 20 to receive comments.
340B Drug Pricing Program
Member

Use Revised AHA Model Letter to Submit Comments on 340B Rebate Model RFI by New April 20 Deadline

HRSA has extended comment deadline and suggested a significantly expanded scope of rebate program.
340B Drug Pricing Program
Member

HHS Releases RFI on New 340B Rebate Model

The Department of Health and Human Services today issued a request for information on a new 340B rebate model program. 
340B Drug Pricing Program